Interpretation of arrhythmogenic effects of COVID-19 disease through ECG

dc.authorid0000-0002-9755-5445en_US
dc.authorid0000-0002-6080-6335en_US
dc.authorid0000-0002-9620-7422en_US
dc.authorid0000-0002-8865-0301
dc.authorid0000-0003-3817-851X
dc.contributor.authorÖztürk, Fatih
dc.contributor.authorKaraduman, Medeni
dc.contributor.authorÇoldur, Rabia
dc.contributor.authorİncecik, Şaban
dc.contributor.authorGüneş, Yılmaz
dc.contributor.authorTuncer, Mustafa
dc.date.accessioned2021-06-23T19:17:10Z
dc.date.available2021-06-23T19:17:10Z
dc.date.issued2020
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractObjective: We aimed to detect the malignant arrhythmic potential of COVID-19 with surface electrocardiographic (ECG) markers. Material and method:Of the ECG parameters PR, QT, QTc, QTd, TPe, and Tpe/QTc were measured in 51 COVID-19 patients and 40 in control subjects. Results: Compared to control group mean QTc (410.8 +/- 24.3 msec vs. 394.6 +/- 20.3 msec,p < .001) and Tpe/QTc (0.19 +/- 0.02 vs. 0.18 +/- 0.04,p= .036) and median QTd (47.52 vs. 46.5) values were significantly higher in COVID-19 patients. Troponin levels were significantly correlated with heart rate (r = 0.387,p = .006) but not with ECG parameters. Conclusion:Several ventricular arrhythmia surface ECG predictors including QTc, QTd, and Tpe/QTc are increased in COVID-19 patients. Since medications used in COVID-19 patients have the potential to affect these parameters, giving importance to these ECG markers may have a significant contribution in decreasing disease-related arrhythmias.en_US
dc.identifier.doi10.1080/13685538.2020.1769058
dc.identifier.endpage1365
dc.identifier.issn1368-5538
dc.identifier.issue5
dc.identifier.pmid32449420en_US
dc.identifier.scopus2-s2.0-85086031226en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1362
dc.identifier.urihttps://doi.org/10.1080/13685538.2020.1769058
dc.identifier.urihttps://hdl.handle.net/20.500.12491/5271
dc.identifier.volume23
dc.identifier.wosWOS:000540091500001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorGüneş, Yılmaz
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofAging Maleen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMalignant Arrhythmiaen_US
dc.subjectCOVID-19en_US
dc.subjectQT Prolongationen_US
dc.subjectECGen_US
dc.titleInterpretation of arrhythmogenic effects of COVID-19 disease through ECGen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
fatih-ozturk.pdf
Boyut:
727.44 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/ Full text